News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,742 Results
Type
Article (5155)
Company Profile (25)
Press Release (228562)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82594)
Career Advice (464)
Deals (15087)
Drug Delivery (8)
Drug Development (19352)
Employer Resources (30)
FDA (3726)
Job Trends (3921)
News (120867)
Policy (7561)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (304)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14965)
ALS (38)
Alzheimer's disease (298)
Antibody-drug conjugate (ADC) (43)
Approvals (3827)
Artificial intelligence (84)
Autoimmune disease (28)
Automation (6)
Bankruptcy (97)
Best Places to Work (2875)
Biosimilars (32)
Biotechnology (24)
Bladder cancer (43)
Brain cancer (7)
Breast cancer (105)
Cancer (925)
Cardiovascular disease (62)
Career advice (396)
Career pathing (3)
CAR-T (75)
CDC (2)
Cell therapy (182)
Cervical cancer (5)
Clinical research (16851)
Collaboration (365)
Compensation (374)
Complete response letters (8)
COVID-19 (313)
CRISPR (14)
C-suite (345)
Cystic fibrosis (28)
Data (1358)
Denatured (1)
Depression (21)
Diabetes (79)
Diagnostics (2128)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (35)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (42849)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39359)
Executive appointments (428)
FDA (4477)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (348)
Gene editing (29)
Generative AI (6)
Gene therapy (107)
GLP-1 (150)
Government (431)
Guidances (197)
Healthcare (5103)
HIV (11)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (41)
Immuno-oncology (8)
Indications (17)
Infectious disease (339)
Inflammatory bowel disease (37)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7899)
IRA (3)
Job creations (1123)
Job search strategy (362)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (108)
Leadership (5)
Legal (2347)
Liver cancer (21)
Longevity (2)
Lung cancer (100)
Lymphoma (71)
Machine learning (3)
Management (10)
Manufacturing (145)
MASH (50)
Medical device (3966)
Medtech (3976)
Mergers & acquisitions (7600)
Metabolic disorders (221)
Multiple sclerosis (19)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (547)
NextGen: Class of 2026 (1681)
Non-profit (737)
Now hiring (6)
Obesity (90)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (40)
Parkinson's disease (51)
Partnered (6)
Patents (54)
Patient recruitment (101)
Peanut (6)
People (25322)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5067)
Phase 2 (7311)
Phase 3 (5820)
Pipeline (2009)
Policy (17)
Postmarket research (626)
Preclinical (2062)
Press Release (66)
Prostate cancer (58)
Psychedelics (3)
Radiopharmaceuticals (110)
Rare diseases (181)
Real estate (1894)
Recruiting (8)
Regulatory (5590)
Reports (17)
Research institute (315)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (50)
Series A (53)
Series B (58)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1029)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (84)
Venture capital (9)
Weight loss (30)
Women's health (6)
Date
Today (34)
Last 7 days (179)
Last 30 days (588)
Last 365 days (9017)
2026 (884)
2025 (9124)
2024 (11128)
2023 (13309)
2022 (18843)
2021 (19844)
2020 (18356)
2019 (13283)
2018 (10281)
2017 (10114)
2016 (9265)
2015 (12218)
2014 (9633)
2013 (7744)
2012 (8379)
2011 (8847)
2010 (8667)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (2)
Asia (11984)
Australia (1713)
California (3590)
Canada (1156)
China (181)
Colorado (146)
Connecticut (163)
Delaware (72)
Europe (25827)
Florida (546)
Georgia (67)
Idaho (24)
Illinois (164)
India (17)
Indiana (107)
Iowa (9)
Japan (168)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (355)
Massachusetts (2842)
Michigan (104)
Minnesota (202)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (47)
New Hampshire (16)
New Jersey (1030)
New Mexico (5)
New York (825)
North Carolina (486)
North Dakota (4)
Northern California (1872)
Ohio (116)
Oklahoma (5)
Oregon (8)
Pennsylvania (612)
Puerto Rico (2)
Rhode Island (20)
South America (279)
South Carolina (17)
Southern California (1326)
Tennessee (63)
Texas (494)
United States (12503)
Utah (115)
Virginia (85)
Washington D.C. (17)
Washington State (298)
West Virginia (2)
Wisconsin (58)
Wyoming (1)
233,742 Results for "invivo corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF
January 19, 2026
·
8 min read
Biotech Beach
Turn Therapeutics Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
In a widely cited in-vivo model of atopic dermatitis, Turn Therapeutics’ atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo.
June 20, 2024
·
2 min read
Deals
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Bruker Corporation announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems.
February 6, 2024
·
3 min read
Small Animal Imaging (In-Vivo) Market Expecting a Surge in Revenue of US$ 1,902 Million By 2032
The global small animal imaging (In-Vivo) market was valued at US$ 1,053 million in 2023.
May 2, 2024
·
7 min read
Press Releases
Zetagen Therapeutics Announces Peer-reviewed Publication of In-Vivo Dose Optimization Findings for ZetaMast™ (Zeta-MBC-005) for Triple Negative Breast Cancer Liver Metastases
June 17, 2025
·
4 min read
Press Releases
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
April 28, 2025
·
7 min read
Press Releases
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
December 10, 2024
·
3 min read
Genetown
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced topline results from the company’s INSPIRE 2.0 study, which was designed to evaluate the safety and probable benefit of InVivo’s investigational Neuro-Spinal Scaffold™, a bioresorbable scaffold-based device in development for patients with acute SCI.
March 9, 2023
·
3 min read
Press Releases
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
·
5 min read
Press Releases
Santhera Appoints Stifel as Corporate Finance Advisor
February 10, 2026
·
2 min read
1 of 23,375
Next
